User contributions for Alara E. Dagsali

25 April 2024

• 22:5322:53, 25 April 2024 diff hist −3‎ Reni Syndrome ‎No edit summary current
• 22:5222:52, 25 April 2024 diff hist −144‎ User:AED ‎No edit summary current
• 22:5122:51, 25 April 2024 diff hist +407‎ User:AED ‎No edit summary
• 22:4822:48, 25 April 2024 diff hist +3‎ Adagrasib ‎No edit summary current
• 22:4822:48, 25 April 2024 diff hist +20‎ 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) ‎No edit summary current
• 22:4522:45, 25 April 2024 diff hist +3‎ Norelgestromin ‎No edit summary current
• 22:4522:45, 25 April 2024 diff hist +11‎ Tranexamic ‎No edit summary current
• 22:4422:44, 25 April 2024 diff hist −11‎ Tranexamic ‎No edit summary
• 22:4122:41, 25 April 2024 diff hist +2‎ Tranexamic ‎No edit summary
• 22:4122:41, 25 April 2024 diff hist −1‎ Tranexamic ‎No edit summary
• 22:4022:40, 25 April 2024 diff hist +14‎ Tranexamic ‎No edit summary Tag: Manual revert
• 22:3922:39, 25 April 2024 diff hist −14‎ Tranexamic ‎No edit summary Tag: Manual revert
• 22:3922:39, 25 April 2024 diff hist +2,941‎ N User:AED ‎ Created page with "==Alara Ece Dagsali== '''Alara Ece Dagsali''' <br>'''Contact:''' email: alaraecedagsai99@gmail.com; +905313614710 ==Medical Education== *School of Medicine (M.D.): Istanbul Medipol University 2021- 2024 Demiroglu Bilim University 2018-2021 ==Pages authored/Co-authored/Collaborated== ===2023=== ====Authored:==== *Reni Syndrome ==Work Experience== *Wikidoc - Associate Editor-In-Chief, 2023 - Current *Yeditepe University Hospitals Cardiac Electrophysiology Lab, Ista..."
• 22:3622:36, 25 April 2024 diff hist +40‎ Alara E. Dagsali ‎No edit summary current

24 April 2024

• 21:2621:26, 24 April 2024 diff hist +14‎ Tranexamic ‎No edit summary Tag: Manual revert
• 21:2621:26, 24 April 2024 diff hist −11‎ Tranexamic ‎No edit summary
• 21:2521:25, 24 April 2024 diff hist −14‎ Template:AlaraE.Dagsali ‎No edit summary current
• 21:2521:25, 24 April 2024 diff hist −2‎ Tranexamic ‎No edit summary Tag: Manual revert
• 21:2321:23, 24 April 2024 diff hist −1‎ Tranexamic ‎No edit summary
• 21:2321:23, 24 April 2024 diff hist +3‎ Tranexamic ‎No edit summary Tag: Visual edit: Switched
• 21:2221:22, 24 April 2024 diff hist −1‎ Tranexamic ‎No edit summary
• 21:2121:21, 24 April 2024 diff hist +88‎ N Template:AlaraE.Dagsali ‎ Created page with " Alara Ece Dagsali, M.D.[mailto:alaraecedagsali99@gmail.com]"
• 21:1421:14, 24 April 2024 diff hist +23,020‎ N Tranexamic ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Tranexamic |aOrAn=a |drugClass=hemophilia drug |indicationType=prevention |indication=Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. |adverseReactions=Thromboembolic Risk Seizures Hypersensitivity Reactions Visual Disturbances Dizzines..."

22 April 2024

• 18:4418:44, 22 April 2024 diff hist 0‎ N File:D2f97c72-bbfb-426e-b742-6e25234ba1ff 2.jpg ‎No edit summary current
• 18:4318:43, 22 April 2024 diff hist 0‎ N File:Ae8d4ea7-c895-403b-a435-56dc4996a3b0.JPG ‎No edit summary current

21 March 2024

• 16:5516:55, 21 March 2024 diff hist +43‎ Norelgestromin ‎No edit summary
• 16:5316:53, 21 March 2024 diff hist +12,388‎ Norelgestromin ‎No edit summary
• 16:2816:28, 21 March 2024 diff hist +22,456‎ Norelgestromin ‎No edit summary
• 08:4608:46, 21 March 2024 diff hist +1,580‎ Norelgestromin ‎No edit summary
• 08:3508:35, 21 March 2024 diff hist +929‎ Norelgestromin ‎No edit summary
• 08:3308:33, 21 March 2024 diff hist +3,183‎ N Norelgestromin ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=NORELGESTROMIN AND ETHINLY ESTRADIOL patch |indicationType=prevention |indication=Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m for whom a combined hormonal contraceptive is appropriate. |hasBlackBoxWarning=Yes |adverseReactions=The following serious adverse reactions with the use of co..."

15 February 2024

• 02:0902:09, 15 February 2024 diff hist +1,330‎ 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) ‎No edit summary
• 02:0102:01, 15 February 2024 diff hist 0‎ 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) ‎No edit summary
• 02:0002:00, 15 February 2024 diff hist −40,428‎ Coronary heart disease in Diabetics ‎ Replaced content with "__NOTOC__ {{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2016 ADA Standards of Medical Care in Diabetes Guidelines<ref name="urlcare.diabetesjournals.org">{{cite web |url=http://care.diabetesjournals.org/content/suppl/2015/12/21/39.Supplement_1.DC2/2016-Standards-of-Care.pdf |title=care.diabetesjournals.org |format= |work= |accessdate=}}</ref>== ===Screening=== {|class="wikitable" | bgcolor="Seashell"|<nowiki>"</nowiki>'''1.'''In asymptomatic..." current Tag: Replaced
• 02:0002:00, 15 February 2024 diff hist +40,625‎ N 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) ‎ Created page with "{{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines f..."
• 01:5501:55, 15 February 2024 diff hist +1,959‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:5301:53, 15 February 2024 diff hist +958‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:4801:48, 15 February 2024 diff hist +5,725‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:3801:38, 15 February 2024 diff hist +2‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:3301:33, 15 February 2024 diff hist 0‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:3201:32, 15 February 2024 diff hist −4‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:1601:16, 15 February 2024 diff hist +1‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:1401:14, 15 February 2024 diff hist +3,056‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:0701:07, 15 February 2024 diff hist −45‎ Coronary heart disease in Diabetics ‎No edit summary
• 01:0401:04, 15 February 2024 diff hist +2,663‎ Coronary heart disease in Diabetics ‎No edit summary
• 00:1700:17, 15 February 2024 diff hist +6,524‎ Coronary heart disease in Diabetics ‎No edit summary
• 00:0500:05, 15 February 2024 diff hist 0‎ Coronary heart disease in Diabetics ‎ →‎Recommendations for nutrition in patients with type 2 diabetes with or without cardiovascular disease (DO NOT EDIT)== Tag: Visual edit
• 00:0400:04, 15 February 2024 diff hist +1,869‎ Coronary heart disease in Diabetics ‎No edit summary Tag: Visual edit: Switched

31 January 2024

• 20:3020:30, 31 January 2024 diff hist +28,883‎ N Adagrasib ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E. Dagsali |genericName=adagrasib |aOrAn=an |indicationType=treatment |indication=KRAZATI is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test [see DOSAGE AND ADMINISTRATION (2.1)], who have received at least one prior systemic therapy. This indication is approved under accelerated approval based on ob..."

21 December 2023

• 08:4608:46, 21 December 2023 diff hist +4,642‎ Coronary heart disease in Diabetics ‎No edit summary